| Literature DB >> 35281730 |
Baptiste Piqueret1, Brigitte Bourachot2,3, Chloé Leroy1, Paul Devienne1, Fatima Mechta-Grigoriou2,3, Patrizia d'Ettorre1,4, Jean-Christophe Sandoz5.
Abstract
Cancer is among the world's leading causes of death. A critical challenge for public health is to develop a noninvasive, inexpensive, and efficient tool for early cancer detection. Cancer cells are characterized by an altered metabolism, producing unique patterns of volatile organic compounds (VOCs) that can be used as cancer biomarkers. Dogs can detect VOCs via olfactory associative learning, but training dogs is costly and time-consuming. Insects, such as ants, have a refined sense of smell and can be rapidly trained. We show that individual ants need only a few training trials to learn, memorize, and reliably detect the odor of human cancer cells. These performances rely on specific VOC patterns, as shown by gas chromatography/mass spectrometry. Our findings suggest that using ants as living tools to detect biomarkers of human cancer is feasible, fast, and less laborious than using other animals.Entities:
Keywords: Biological sciences; Cancer; Cell biology
Year: 2022 PMID: 35281730 PMCID: PMC8914326 DOI: 10.1016/j.isci.2022.103959
Source DB: PubMed Journal: iScience ISSN: 2589-0042
Figure 1Behavioral setups and results of the conditioning experiments
(A) Schema of the experimental arena used during the conditioning of ants. A reward was placed above a tube with the conditioned stimulus (CS), and we recorded the time needed by the ant to find the reward during three conditioning trials.
(B) For the memory tests, we used a slightly different setup, where no reward was given, and two odors were present (the CS and a novel odor, N). The time spent by the ant in the vicinity of each odor area (dashed lines) as well as two unscented control areas, was recorded.
(C and D) Ants were conditioned to IGROV-1 (C, n = 36) and underwent memory tests (D).
(E and F) ants were conditioned (E) to MCF-7 cancer cells (n = 25) or MCF-10A healthy cells (n = 22), and tested with these samples (F).
(G and H) Ants were conditioned (G) to MCF-7 (n = 25) or MDA-MD-231 cancer cells (n = 24) and tested with these samples (H).
For the conditioning (C, E, and G), different letters indicate significant differences between trials (LMM, p < 0.05, after Bonferroni correction). For the memory tests (D, F, and H), open circles (CS area) and squares (N area) represent the mean time, whereas error bars show CIs (95%) of the two successive pooled memory tests. Significant differences between stimuli are indicated with asterisks (LMM, ∗∗: p ≤ 0.01).
See also Tables S1 and S2; Datas S1 and S2.
Figure 2Principal component analysis and matrix of dissimilarities of cell sample VOC profiles
(A) Plot of the first three Principal Components (PC), explaining 60.8% of the total variance. Cell line samples are well separated by the Principal Component Analysis (PCA).
(B) Variables used in the PCA showing the correlation between the first three PCs and the original variables. The angle between the vectors represents the correlation between the variables and the PCs. The length of each vector indicates how well the variable is represented in the plot, and consequently its contribution to the discrimination of cell types. Identification of the VOCs: (1) styrene, (2) oxime-, methoxy-phenyl, (3) benzaldehyde, (4) phenol, (5) aromatic compound, (6) decane, (7) 1-hexanol, 2-ethyl-, (8) benzyl-alcohol, (9) benzeneacetaldehyde, (10) hydrocarbon, (11) decane, 4-methyl-, (12) hydrocarbon, (13) acetophenone, (14) undecane, (15) hydrocarbon, (16) nonanal, (17) unidentified VOC, (18) dodecane, (19) decanal, (20) benzaldehyde, 3,4-dimethyl, (21) unidentified VOC, (22) benzene, 1,3-bis(1,1-dimethylethyl)-, (23) decanol, (24) unidentified VOC, (25) 2-undecanone.
(C) Euclidian distances were calculated using the first eight PCs of the PCA (which represent 90.4% of the total variance). Red indicates high dissimilarities, whereas green indicates high similarities between samples.
See also Tables S3 and S4; Figures S3–S28; Data S3–S5.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| DMEM (Dulbecco modified Eagle’s minimal essential medium) | GE Healthcare Hyclone | SH30243.01 |
| Fetal bovine serum (FBS) | Biosera | #1003/500 |
| Penicillin - streptomycin | Gibco | #15140122 |
| decane | Sigma Aldrich, Saint-Louis, MO, USA | CAS 124-18-5 |
| benzyl alcohol | Sigma Aldrich, Saint-Louis, MO, USA | CAS 100-51-6 |
| Acetophenone | Sigma Aldrich, Saint-Louis, MO, USA | CAS 98-86-2 |
| undecane | Sigma Aldrich, Saint-Louis, MO, USA | CAS 1120-21-4 |
| nonanal | Sigma Aldrich, Saint-Louis, MO, USA | CAS 124-19-6 |
| dodecane | Sigma Aldrich, Saint-Louis, MO, USA | CAS 112-40-3 |
| decanal | Sigma Aldrich, Saint-Louis, MO, USA | CAS 112-31-2 |
| 3,4-dimethylbenzaldehyde | Sigma Aldrich, Saint-Louis, MO, USA | CAS 5973-71-7 |
| benzaldehyde | Sigma Aldrich, Saint-Louis, MO, USA | CAS 100-52-7 |
| 2-Undecanone | Sigma Aldrich, Saint-Louis, MO, USA | CAS 112-12-9 |
| styrene | Sigma Aldrich, Saint-Louis, MO, USA | CAS 100-42-5 |
| benzene, 1,3-bis(1,1-dimethylethyl) | Sigma Aldrich, Saint-Louis, MO, USA | CAS 140431-85-2 |
| decanol | Sigma Aldrich, Saint-Louis, MO, USA | CAS 112-30-1 |
| Human: IGROV-1 | Curie Institute, Paris, France | RRID: CVCL_1304 |
| Human: MCF-7 | Curie Institute, Paris, France | RRID: CVCL_0031 |
| Human: MCF-10A | Curie Institute, Paris, France | RRID: CVCL_0598 |
| Human: MDA-MB-231 | Curie Institute, Paris, France | RRID: CVCL_0062 |
| Ants: | Wild: Forest of Ermenonville (France, 49°09′51.5″ N, 2°36′49.2″ E | N/A |
| R software | ||
| MSD ChemStation software version E.02.01.1177 | Agilent Technologies | |
| NIST library | NIST | |
| Ethoc software | CRCA | |
| SPME fiber (50/30 μm DVB/CAR/PDMS) | Supelco | |
| Agilent Technologies 7890A gas-chromatograph | Agilent Technologies, Les Ulis Cedex, France | |